Two Sigma Investments
CTXR icon

Two Sigma Investments’s Citius Pharmaceuticals CTXR Stock Holding History

Two Sigma Investments’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8K Sell
13,138
-47,700
-78% -$38.5K ﹤0.01% 4524
2025
Q4 		$47.3K Buy
60,838
+39,035
+179% +$48.8K ﹤0.01% 3942
2025
Q3 		$27K Buy
21,803
+8,929
+69% +$12.4K ﹤0.01% 3579
2025
Q2 		$20.5K Buy
+12,874
New +$11.8K ﹤0.01% 3118
2023
Q3 		– Sell
-1,561
Closed -$46.8K – 2991
2023
Q2 		$46.8K Buy
+1,561
New +$51.4K ﹤0.01% 2837
2022
Q3 		– Sell
-2,226
Closed -$51K – 2527
2022
Q2 		$51K Buy
+2,226
New +$61K ﹤0.01% 2343
2022
Q1 		– Sell
-6,478
Closed -$249K – 3016
2021
Q4 		$249K Buy
6,478
+713
+12% +$32.3K ﹤0.01% 3775
2021
Q3 		$293K Buy
+5,765
New +$289K ﹤0.01% 3687

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Two Sigma Investments's CTXR Position: Q1 2026 in Review

Two Sigma Investments reduced its Citius Pharmaceuticals (CTXR) stake by 78% in Q1 2026, selling an estimated $38.5K and leaving 13,138 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4524.

Two Sigma Investments first reported a position in CTXR in Q3 2021 and has held it in 8 quarters since. The position peaked at $293K in Q3 2021. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • Two Sigma Investments held 13,138 shares of Citius Pharmaceuticals worth $11.8K as of Q1 2026.
  • Two Sigma Investments sold 47,700 Citius Pharmaceuticals shares in Q1 2026, an estimated $38.5K.
  • Citius Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4524 holding.
  • Two Sigma Investments first reported a position in Citius Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
  • Two Sigma Investments's Citius Pharmaceuticals position peaked at $293K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.